Onelife pursues a new approach to Life Science and is becoming a recognized thought leader in the field of conjugating profit and sustainable growth for its clients, investors and partners.

Onelife wants to make a real contribution to the manifold challenges in the Life Science sector capitalizing on its unique industry insights and expertise in three distinct areas:

FUND
Prospera Senectute Fund is a new ethical Life Science sector fund focusing on healthy aging. The Fund benefits from Onelife unique view and expertise regarding science, demographic changes and in-depth knowledge of the industry.

ADVISORY
Onelife virtual network and sound experience in the Life Science sector provides clients such as financial institutions, Life Science companies and family offices with advices for improving evaluation and complex handling of pharmaceutical and biotechnology projects, bio-finance data or sophisticated cost controlling and investment decision processes.

LICENSES
Onelife supports investors and companies in strategic ventures including in/out license of Life Science projects, acquisition of new technologies and M&As.

A new approach to
Life Science

© 2010 Onelife

NEWS:

BLOCKSLAB project now is live!

ONELIFE will be present at Bio Pharm 2010 in Boston

ONELIFE present its case study at Univerita' Svizzera Italiana during the Biobusiness Course

ONELIFE launch the new platform Bench-2-Bed